Revance Therapeutics, Inc. is an innovative biotechnology company focused on developing and commercializing advanced therapies for aesthetic and therapeutic indications. Founded in 2006 and headquartered in Nashville, Tennessee, Revance is committed to leveraging cutting-edge science and technology to transform patient care and improve outcomes across various medical fields.
Aesthetic Medicine: Revance is well-known for its advancements in aesthetic treatments, particularly through its flagship product, Dysport®. Dysport® is an injectable treatment for facial wrinkles and other aesthetic concerns. The company is dedicated to expanding its portfolio with innovative solutions that address various cosmetic needs.
Therapeutic Products: Beyond aesthetics, Revance focuses on developing therapeutic products for a range of medical conditions. This includes their investigational treatments for chronic pain, autoimmune diseases, and other serious health conditions. Their therapeutic pipeline emphasizes novel approaches and breakthrough therapies.
Botulinum Toxin Products: Revance’s RHA® Collection of resilient hyaluronic acid fillers is designed for facial contouring and wrinkle treatment, showcasing their commitment to advanced aesthetic solutions. Their products are known for their effectiveness and long-lasting results.
Revance operates with a global perspective, aiming to bring its innovative therapies to patients around the world. The company’s products are marketed and distributed internationally, with a focus on expanding their reach in both established and emerging markets.
Browse Our Research Portfolio In Revance Therapeutics Markets
Health Care
Health Care
Health Care
Health Care Providers and Services
Pharmaceuticals
Pharmaceuticals
Health Care Services
Pharmaceuticals
Pharmaceuticals
About Technavio
With unparalleled market insights, our research is designed to elevate your business to new heights. Technavio stands at the forefront of market research with a global perspective. Our approach is grounded in four key principles: accessible reports, comprehensive industry analysis, a focus on innovative and emerging technologies, and competitive pricing. We are dedicated to empowering companies and executives to make informed, timely, and strategic decisions.